CONSONAR, created in 1967 (Switzerland), from 2951 sister brands and 17477 competing brands. The CONSONAR brand is owned by NOVARTIS N, a company listed in Zurich. Its International Securities Identification Number (ISIN) is CH0012005267. CONSONAR belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(CONSONAR)
over 5 years*
CHF 99.43